Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals

R&D teams are starting to advance AI capabilities faster than they can translate them into measurable business value, creating mounting friction between scientific progress and operational reality. In this episode, Aziz Nazha, Global Head of AI Innovations Institute at Incyte Pharmaceuticals, examines how culture, talent, infrastructure, and expectation‑setting determine whether AI meaningfully improves drug discovery and development. He highlights the practical shifts required — from redesigning workflows to disciplined upskilling and targeted validation cycles — to ensure AI adoption accelerates cycle times rather than getting stalled by organizational bottlenecks. This episode is sponsored by Deloitte. Learn how brands like Deloitte work with Emerj and other Emerj Media options at go.emerj.com/partner

You can listen to Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals online on Radio and Podcast. Open the player on this page to stream the available audio.

Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals is an episode from Artificial Intelligence in Industry with Dan Faggella by Daniel Faggella.

This episode is 30:57 long.

This episode was published on Apr 16, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Artificial Intelligence in Industry with Dan Faggella when more episodes are available from the podcast feed.